Purdue Pharma, the makers and marketers of the highly addictive opioid OxyContin, and the family that owned the company, the Sackler family, have agreed to pay $7.4 billion to individuals ...

The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family ...

The Sackler family and its company, Purdue Pharma, reached a settlement with a coalition of 15 states in relation to their involvement in the United States opioid crisis. If approved, the January ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, replaces a ...

The Sackler family and Purdue Pharma have agreed to a combined $7.4 billion settlement, according to the Utah Department of Commerce. Utah’s share would be $57 million of it if the state agrees ...

Not every state has signed on yet. Under the new proposal, members of the Sackler family would also give up ownership of Purdue. They've already stepped down from the company's board and have ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and other states said.

If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

The deal, agreed to by Purdue Pharma, the Sackler family members who own the company and lawyers representing state and local governments and thousands of victims of the opioid crisis, represents ...